Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
CEVEC Pharmaceuticals
508
CEVEC Pharmaceuticals
Technology
Biotechnology
CEVEC Pharmaceuticals develops therapeutic proteins and monoclonal antibodies with human glycosylation patterns.
Suggest edits
Founded
2001
Raised
$14M
Follow us
Companies in the same industry
Avivagen Inc.
Algaeon, Inc.
Aclaris Therapeutics, Inc.
Marina Biotech
Labster
TiGenix
SyntheX
Adient Medical, Inc.
Ichor Therapeutics
SonarMed, Inc.
Alexa global traffic share
Overview
Funding
2
Add info
Latest funding
$8,628,000
Venture capital - 2011
$5,400,000
Venture capital (Series B) - 2010
Team Size
10+
Employees
I work here
Location
Germany
Headquarters
Explore Germany
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when CEVEC Pharmaceuticals makes some noise.
